Tags: Drug.

S-40503 is an investigational selective androgen receptor modulator (SARM) developed by the Japanese company Kaken Pharmaceuticals which was developed for the treatment of osteoporosis.

S-40503.svg
IUPAC name
2-[4-(dimethylamino)-6-nitro-1234-tetrahydroquinolin-2-yl]-2-methylpropan-1-ol
PubChem
9879175

Loading...

This page contains content from the copyrighted Wikipedia article "S-40503"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.